Case Report: A First Nation Man’s Journey with Severe Insulin Resistance Syndrome
DOI:
https://doi.org/10.58931/cdet.2023.1319Abstract
James (a pseudonym) was born in the 1940s near Vancouver Island, British Columbia, to a Coast Salish family. His schooling was the imposed residential school system whereby Indigenous children were removed from their homes and communities and sent to schools in communities far away. His siblings attended various residential schools, so during his three years at such schools he saw them only in the summer time. His treatment during his schooling fostered a deep distrust of physicians and nurses. In addition he lost much of his native language and culture during this time. He graduated from Queen Elizabeth (High) School in North Surrey, British Columbia, where he was the only Indigenous student. James attended Vancouver Vocational School before returning to Vancouver Island to work as a band manager for his First Nation community. He married Mary (a pseudonym) and together they raised four children. Today he works as an Elder in Residence with post-secondary institutions on Vancouver Island.
References
Malek R, Chong AY, Lupsa BC, et al. Treatment of type B insulin resistance: a novel approach to reduce insulin receptor autoantibodies. J Clin Endocrinol Metab. 2010;95(8):3641-3647. DOI: https://doi.org/10.1210/jc.2010-0167
Flier JS, Kahn CR, Jarrett DB, et al. Characterization of antibodies to the insulin receptor: a cause of insulin-resistant diabetes in man. J Clin Invest. 1976;58:1442-1449. DOI: https://doi.org/10.1172/JCI108600
Brown RJ, Joseph J, Cochran E, et al. Type B insulin resistance masquerading as ovarian hyperthecosis. J Clin Endocrinol Metab. 2017;102(6):1789-1791.
Willard DL, Stevenson M, Steenkamp D. Type B insulin resistance syndrome. Curr Opin Endocrinol Diabetes Obes. 2016;23:318-323. DOI: https://doi.org/10.1097/MED.0000000000000263
Arioglu E, Andewelt A, Diabo C, et al. Clinical course of the syndrome of autoantibodies to the insulin receptor (type B insulin resistance): a 28-year perspective. Medicine (Baltimore). 2002;81(2):87-100. DOI: https://doi.org/10.1097/00005792-200203000-00001
Klubo-Gwiezdzinska J, Lange M, Cochran E, at al. Combined immunosuppressive therapy induces remission in patients with severe type B insulin resistance: a prospective cohort study. Diabetes Care. 2018;41(11): 2353-2360. DOI: https://doi.org/10.2337/dc18-0884
Cochran E, Musso C, Gorden P. The use of U-500 in patients with extreme insulin resistance. Diabetes Care. 2005;28(5):1240-1244. DOI: https://doi.org/10.2337/diacare.28.5.1240
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Canadian Diabetes & Endocrinology Today
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.